Detalhe da pesquisa
1.
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo, and IVIVR.
Pharm Dev Technol
; 28(2): 190-199, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688610
2.
Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
Pharm Dev Technol
; 26(4): 381-389, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538232
3.
Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate.
Drug Dev Ind Pharm
; 46(2): 318-328, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31976771
4.
Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
Pharm Dev Technol
; 24(9): 1063-1075, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654677
5.
Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation.
Pharm Dev Technol
; 22(7): 860-870, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26555615
6.
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.
J Nanobiotechnology
; 14: 32, 2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102110
7.
Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.
Drug Dev Ind Pharm
; 42(5): 707-19, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26289000
8.
Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.
Pharm Res
; 31(8): 2124-39, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24558012
9.
Release optimization of epidermal growth factor from PLGA microparticles.
Pharm Dev Technol
; 19(5): 539-47, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23777385
10.
Preparation and Physicochemical Characterization of Hyaluronic Acid-Lysine Nanogels Containing Serratiopeptidase to Control Biofilm Formation.
Sci Rep
; 14(1): 6111, 2024 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480832
11.
PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells.
Int J Pharm
; 655: 124024, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537920
12.
Targeted pH- and redox-responsive AuS/micelles with low CMC for highly efficient sonodynamic therapy of metastatic breast cancer.
Biomater Adv
; 158: 213771, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271801
13.
Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel.
Daru
; 21(1): 58, 2013 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23866721
14.
Gold cluster encapsulated liposomes: theranostic agent with stimulus triggered release capability.
Med Oncol
; 40(5): 126, 2023 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961614
15.
Co-delivery of simvastatin and microRNA-21 through liposome could accelerates the wound healing process.
Biomater Adv
; 154: 213658, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866233
16.
Development of osteon-like scaffold-cell construct by quadruple coaxial extrusion-based 3D bioprinting of nanocomposite hydrogel.
Biomater Adv
; 145: 213254, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584583
17.
L-asparaginase immobilization in supramolecular nanogels of PEG-grafted poly HPMA and bis(α-cyclodextrin) to enhance pharmacokinetics and lower enzyme antigenicity.
Colloids Surf B Biointerfaces
; 225: 113234, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934612
18.
Redox-responsive waterborne polyurethane nanocarriers for targeted doxorubicin delivery.
Int J Pharm
; 628: 122275, 2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265661
19.
Novel biodegradable molecularly imprinted polymer nanoparticles for drug delivery of methotrexate anti-cancer; synthesis, characterization and cellular studies.
Daru
; 30(2): 289-302, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087235
20.
Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells.
J Drug Target
; 30(5): 522-533, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482780